Antithrombotic therapy in atrial fibrillation

被引：259

作者：

Laupacis, A ^{[1
]}

Albers, G ^{[1
]}

Dalen, J ^{[1
]}

Dunn, MI ^{[1
]}

Jacobson, AK ^{[1
]}

Singer, DE ^{[1
]}

机构：

[1] Ottawa Hosp, Clin Epidemiol Unit, Ottawa, ON K1Y 4E9, Canada

来源：

CHEST | 1998年 / 114卷 / 05期

关键词：

D O I：

10.1378/chest.114.5_Supplement.579S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：579S / 589S

页数：11

共 73 条

[1]

ALKA S, 1993, AM HEART J, V126, P722

[2]

Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273

[3]

[Anonymous], 1997, ARCH INTERN MED, V157, P1237

[4]

[Anonymous], 1993, LANCET, V342, P1255, DOI DOI 10.1016/0140-6736(93)92358-Z

[5] ARTERIAL EMBOLISM IN THYROTOXICOSIS WITH ATRIAL-FIBRILLATION [J].

BARSELA, S ;

EHRENFELD, M ;

ELIAKIM, M .

ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (09) :1191-1192

[6] EFFICACY OF ANTICOAGULANT THERAPY IN PREVENTING EMBOLISM RELATED TO DC ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION [J].

BJERKELUND, CJ ;

ORNING, OM .

AMERICAN JOURNAL OF CARDIOLOGY, 1969, 23 (02) :208-+

[7]

BLACK I W, 1992, Journal of the American College of Cardiology, V19, p314A

[8]

Blackshear JL, 1996, LANCET, V348, P633

[9] OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES [J].

CANNEGIETER, SC ;

ROSENDAAL, FR ;

WINTZEN, AR ;

VANDERMEER, FJM ;

VANDENBROUCKE, JP ;

BRIET, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :11-17

[10]

Chan Kwan-Leung, 1998, Annals of Internal Medicine, V128, P639

← 1 2 3 4 5 6 7 8 →